[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease
…, D Hashimoto, Y Nakamura, N Inui, K Yokomura… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease. A Preliminary Study
…, T Shirai, K Yasuda, K Yokomura… - Annals of the …, 2014 - atsjournals.org
Rationale: Patients with Mycobacterium avium complex pulmonary disease are frequently
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …
[HTML][HTML] Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study
…, N Inui, T Iwashita, S Kuroishi, K Yokomura… - Respiratory …, 2017 - Elsevier
Background Although the accurate diagnosis of pleuroparenchymal fibroelastosis (PPFE)
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …
[HTML][HTML] Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients
…, T Fujisawa, N Koshimizu, K Yokomura… - BMC Pulmonary …, 2012 - Springer
Background Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently reported group
of disorders characterized by fibrotic thickening of the pleural and subpleural parenchyma …
of disorders characterized by fibrotic thickening of the pleural and subpleural parenchyma …
Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders …
…, T Kakutani, Y Amano, Y Ozawa, T Matsui, K Yokomura… - Respiration, 2018 - karger.com
Background: High-flow nasal cannula (HFNC) oxygen therapy may provide effective respiratory
management of hypoxemic respiratory failure in patients with interstitial lung disease (…
management of hypoxemic respiratory failure in patients with interstitial lung disease (…
Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer
…, T Koyauchi, M Tanahashi, H Niwa, K Yokomura… - Medical Oncology, 2019 - Springer
Early elevation of inflammatory cytokines, such as IL-6 or TNF-α, or CRP, which is a surrogate
marker for IL-6, following commencement of PD-1/L1 inhibitors (PD1-I) may represent …
marker for IL-6, following commencement of PD-1/L1 inhibitors (PD1-I) may represent …
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial
…, K Mori, M Mikamo, H Matsuda, K Yokomura… - …, 2021 - Wiley Online Library
Background and objective The efficacy of combination therapy with corticosteroids and CNI,
TAC and CsA, for PM/DM‐ILD has been described retrospectively. However, it remains …
TAC and CsA, for PM/DM‐ILD has been described retrospectively. However, it remains …
[HTML][HTML] Impact of preexisting interstitial lung disease on acute, extensive radiation pneumonitis: retrospective analysis of patients with lung cancer
…, T Ishihara, N Inui, K Yamada, K Yokomura… - PloS one, 2015 - journals.plos.org
Introduction This study investigated the clinical characteristics and predictive factors for
developing acute extended radiation pneumonitis with a focus on the presence and radiological …
developing acute extended radiation pneumonitis with a focus on the presence and radiological …
Aprepitant in patients with advanced non-small-cell lung cancer receiving carboplatin-based chemotherapy
…, S Kuroishi, H Nakano, Y Nakamura, K Yokomura… - Lung cancer, 2014 - Elsevier
Objectives Chemotherapy-induced nausea and vomiting (CINV) is an unanswered problem
in cancer therapy. We evaluated the efficacy and safety of triple antiemetic therapy with …
in cancer therapy. We evaluated the efficacy and safety of triple antiemetic therapy with …
[HTML][HTML] Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
…, T Fujisawa, N Inui, Y Nakamura, K Yokomura… - Respiratory …, 2022 - Springer
Background Patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD),
like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute …
like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute …